Canada's manufacturers of brand name medicines have failed to invest 10 per cent of their annual sales into research and development as they have long promised. The industry earned a record $20 billion in 2016, yet spent just four per cent of that on in-house R&D in Canada.
from CBC | Health News http://ift.tt/2jCAaC1
ABOUT THE AUTHOR
Hello We are OddThemes, Our name came from the fact that we are UNIQUE. We specialize in designing premium looking fully customizable highly responsive blogger templates. We at OddThemes do carry a philosophy that: Nothing Is Impossible
0 commentaires:
Enregistrer un commentaire